Immunomodulatory effects of polysaccharopeptide in immunosuppressed mice induced by cyclophosphamide.

Rui Huang,Jun Zhang,Yong Liu,Yingying Hao,Chenchen Yang,Kangkang Wu,Shufeng Cao,Chao Wu
DOI: https://doi.org/10.3892/mmr.2013.1542
IF: 3.423
2013-01-01
Molecular Medicine Reports
Abstract:Polysaccharopeptide (PSP) is well known for its immunoregulatory effects. In the present study, the effect of PSP on white blood cell (WBC) count, T lymphocyte subsets, B lymphocytes, Th1/Th2 balance and negative immune regulators was investigated using an immunosuppressed mouse model. The results demonstrated that the WBC count and the absolute number of CD3(+)CD4(+) T cells, CD3(+)CD8(+) T cells and CD3(-)CD19(+) B cells in the peripheral blood were increased in PSP-treated groups as compared with the cyclophosphamide (Cy) group. In addition, PSP reduced interleukin (IL)-4 and GATA binding protein 3 (GATA-3) mRNA relative expression levels and elevated the ratios of IL-2/IL-4 and the transcription factors, T-box-containing protein/GATA-3. The relative mRNA expression levels of the forkhead/winged-helix transcription factor box protein 3 (Foxp3), programmed death-1 (PD-1) and IL-10 were also downregulated by PSP. These observations indicate that the immunoregulatory effects of PSP are associated with restoration of WBC number, improving the absolute number of T lymphocyte subsets and B lymphocytes, inducing the Th1/Th2 response and downregulating the negative immune regulators, Foxp3, PD-1 and IL-10.
What problem does this paper attempt to address?